
American Well Corporation (AMWL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
American Well Corporation is a telehealth business enabling digital healthcare delivery. The company is headquartered in Boston, Massachusetts.
| Revenue (TTM) | $218.53M |
| Gross Profit (TTM) | $114.91M |
| EBITDA | $-39.89M |
| Operating Margin | -19.60% |
| Return on Equity | -29.10% |
| Return on Assets | -12.70% |
| Revenue/Share (TTM) | $13.25 |
| Book Value | $13.07 |
| Price-to-Book | 1.02 |
| Price-to-Sales (TTM) | 1.04 |
| EV/Revenue | 0.145 |
| EV/EBITDA | -0.81 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -26.60% |
| Shares Outstanding | $15.36M |
| Float | $11.93M |
| % Insiders | 5.39% |
| % Institutions | 50.83% |
Volatility is currently contracting

American Well Corporation (AMWL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.

INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.

BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced the Department of Veterans Affairs (VA) has declared its intent for the Company to deploy its virtual health platform within the VA enterprise and help power the modernization of the VA's digital health infrastructure.

BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms Industry. The recognition validates Amwell's ability to address healthcare fragmentation through a unified platform that orchestrates consumer experiences, clinician workflows, care programs, and partner solutions.

BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, today announced that members of the Amwell management team will participate in the following upcoming investor conferences:

American Well (AMWL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

American Well (AMWL) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

BOSTON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announces that on August 7, Amwell made grants of RSUs covering an aggregate of 6,679 shares of its Class A common stock to two new non-executive employees. The grants were offered as material inducement to the employees' entry into employment with Amwell.

American Well Corporation (AMWL) Q2 2026 Earnings Call Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AMWL and any ticker you trade — then tracks every position and per-strategy win rate.